Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?

References

1. ↵
   1. Altinisik HB,
   2. Altinisik U,
   3. Uysal S,
   4. Sacar S,
   5. Simsek T,
   6. Demiraran Y

   (2018) Are fetuin-A levels beneficial for estimating timing of sepsis occurrence. Saudi Med J 39:679–684.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Vashist SK,
   2. Schneider EM,
   3. Venkatesh AG,
   4. Luong JHT

   (2017) Emerging human fetuin-A assays for biomedical diagnostics. Trends Biotechnol 35:407–421.

   OpenUrl
3. ↵
   1. Agilli M,
   2. Aydin FN,
   3. Cayci T,
   4. Kurt YG

   (2015) Relationship between fetuin-A levels and bone mineral density. Osteoporos Int 26:839–840.

   OpenUrl
4. ↵
   1. Karampela I,
   2. Kandri E,
   3. Antonakos G,
   4. Vogiatzakis E,
   5. Christodoulatos GS,
   6. Nikolaidou A,
   7. et al.

   (2017) Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis:a prospective study. J Crit Care 41:78–85.

   OpenUrl
5. ↵
   1. Li W,
   2. Zhu S,
   3. Li J,
   4. Huang Y,
   5. Zhou R,
   6. Fan X,
   7. et al.

   (2011) A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One 6:e16945.

   OpenUrlCrossRefPubMed
6. ↵
   1. Dalamaga M,
   2. Karampela I

   (2018) Fetuin-A to adiponectin ratio is a promising prognostic biomarker in septic critically ill patients. J Crit Care 44:134–135.

   OpenUrl
7. ↵
   1. Wang H,
   2. Sama AE

   (2012) Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med 12:625–633.

   OpenUrlCrossRefPubMed
8. ↵
   1. Gluba-Brzózka A,
   2. Michalska-Kasiczak M,
   3. Franczyk-Skóra B,
   4. Nocuń M,
   5. Banach M,
   6. Rysz J

   (2014) Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis 13:135.

   OpenUrl
9. 1. Vashist SK,
   2. Schneider EM,
   3. Luong JH

   (2015) Rapid sandwich ELISA-based in vitro diagnostic procedure for the highly-sensitive detection of human fetuin A. Biosens Bioelectron 67:73–78.

   OpenUrl
10. 1. Jirak P,
    2. Mirna M,
    3. Wernly B,
    4. Paar V,
    5. Thieme M,
    6. Betge S,
    7. et al.

    (2018) Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease (PAD). Minerva Med, DOI:10.23736/S0026-4806.18.05628-8.
11. 1. Mukhopadhyay S,
    2. Pandit BN,
    3. Saran RK,
    4. Mazumdar K,
    5. Yusuf J,
    6. Minhas HS

    (2014) Systemic and local levels of fetuin-a in calcified mitral valves of rheumatic heart disease. J Heart Valve Dis 23:55–65.

    OpenUrl
12. ↵
    1. Vashist SK1,
    2. Schneider EM,
    3. Luong JH

    (2014) Surfaceplasmon resonance-based immunoassay for human fetuin A. Analyst 139:2237–2242.

    OpenUrl